In addition, on the contrary, none of the patients who received neoadjuvant chemotherapy/TKIs had a pCR in our study, indicating the potential of neoadjuvant PD-(L)1 blockade-based treatment in patients with oncogene-positive NSCLC. Here, CD274 is linked to non-small cell lung carcinoma.